Lipofen is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Fenofibrate.
| Product ID | 62559-305_25f18a1a-2283-469b-a18f-e573fa72a1ee |
| NDC | 62559-305 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lipofen |
| Generic Name | Fenofibrate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-09-24 |
| Marketing Category | NDA / |
| Application Number | NDA021612 |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Substance Name | FENOFIBRATE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-09-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 66869-147 | LIPOFEN | LIPOFEN |
| 66869-137 | LIPOFEN | LIPOFEN |
| 0093-7755 | Fenofibrate | Fenofibrate |
| 0093-7756 | Fenofibrate | Fenofibrate |
| 0115-0511 | Fenofibrate | FENOFIBRATE |
| 0115-0522 | Fenofibrate | FENOFIBRATE |
| 0115-0533 | Fenofibrate | FENOFIBRATE |
| 0115-1522 | Fenofibrate | Fenofibrate |
| 0115-1523 | Fenofibrate | Fenofibrate |
| 0115-5511 | FENOFIBRATE | FENOFIBRATE |
| 0115-5522 | FENOFIBRATE | FENOFIBRATE |
| 0074-3173 | Tricor | Fenofibrate |
| 0074-3189 | Tricor | Fenofibrate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LIPOFEN 78688955 3403114 Live/Registered |
Cipher Pharmaceuticals Inc. 2005-08-09 |